These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35881225)

  • 61. Informatics Tools in Deprescribing and Medication Optimization in Older Adults: Development and Dissemination of VIONE Methodology in a High Reliability Organization.
    Winter SG; Sedgwick C; Wallace-Lacey A; Dickerson K; Battar S; Hung W
    Clin Ther; 2023 Oct; 45(10):928-934. PubMed ID: 37690914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deprescribing antihypertensive drugs in frail older adults.
    Reeve E; Gnjidic D; Langford AV; Hilmer SN
    Aust Prescr; 2024 Jun; 47(3):85-90. PubMed ID: 38962389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rational deprescribing in the elderly.
    Williams S; Miller G; Khoury R; Grossberg GT
    Ann Clin Psychiatry; 2019 May; 31(2):144-152. PubMed ID: 31046036
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.
    Todd A; Jansen J; Colvin J; McLachlan AJ
    BMC Geriatr; 2018 Nov; 18(1):295. PubMed ID: 30497404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inappropriate polypharmacy management versus deprescribing: A review on their relationship.
    Zidan A; Awaisu A
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):6-14. PubMed ID: 37350370
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China.
    Tan J; Wang M; Pei X; Sun Q; Lu C; Wang Y; Zhang L; Wu C
    BMC Geriatr; 2022 Jun; 22(1):492. PubMed ID: 35676628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Optimising Medications for Patients With Cancer and Multimorbidity: The Case for Deprescribing.
    Turner JP; Kantilal K; Kantilal K; Holmes HM; Koczwara B
    Clin Oncol (R Coll Radiol); 2020 Sep; 32(9):609-617. PubMed ID: 32563549
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Community-dwelling older people's attitudes towards deprescribing in Canada.
    Sirois C; Ouellet N; Reeve E
    Res Social Adm Pharm; 2017; 13(4):864-870. PubMed ID: 27663392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deprescribing for older adults in Australia: factors influencing GPs.
    Gillespie R; Mullan J; Harrison L
    Aust J Prim Health; 2018 Jan; 24(6):463-469. PubMed ID: 30423283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Deprescribing for Better Patient Outcomes in Chronic Long Term Care and Role of Clinical Pharmacological Review.
    Samajdar SS; Mukherjee S; Tripathi SK; Pal J; Joshi S
    J Assoc Physicians India; 2021 Nov; 69(11):11-12. PubMed ID: 34781620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens.
    Rochon PA; Petrovic M; Cherubini A; Onder G; O'Mahony D; Sternberg SA; Stall NM; Gurwitz JH
    Lancet Healthy Longev; 2021 May; 2(5):e290-e300. PubMed ID: 36098136
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deprescribing in older people.
    O'Mahony MS; Parbhoo A
    Br J Hosp Med (Lond); 2020 Jan; 81(1):1-9. PubMed ID: 32003625
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deprescribing Blood Pressure Treatment in Long-Term Care Residents.
    Odden MC; Lee SJ; Steinman MA; Rubinsky AD; Graham L; Jing B; Fung K; Marcum ZA; Peralta CA
    J Am Med Dir Assoc; 2021 Dec; 22(12):2540-2546.e2. PubMed ID: 34364847
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?
    Peterson ED; Rich MW
    JAMA; 2020 May; 323(20):2024-2026. PubMed ID: 32453349
    [No Abstract]   [Full Text] [Related]  

  • 80. Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials.
    Crisafulli S; Luxi N; Coppini R; Capuano A; Scavone C; Zinzi A; Vecchi S; Onder G; Sultana J; Trifirò G
    BMC Fam Pract; 2021 Oct; 22(1):208. PubMed ID: 34666689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.